TORREY trial: seralutinib associated with reduced pulmonary vascular resistance in PAH Presented ByProf. Robert Frantz, Mayo Clinic, MN, USA TrialPhase 2, TORREY ConferenceATS 2023 12 June, 2023 16:16
Practice-changing results for ensifentrine in COPD Presented ByProf. Antonio Anzueto, University of Texas Health San Antonio, TX, USA TrialPhase 3, ENHANCE-1, ENHANCE-2 ConferenceATS 2023 12 June, 2023 16:10
Vitamin D for asthma protection: what is the optimal timing? Presented ByDr Lourdes Ramirez, Brigham and Women’s Hospital, MA, USA TrialPhase 3, VDAART ConferenceATS 2023 12 June, 2023 16:15
Remarkable results for novel biologic therapy for asthma Presented ByDr Benjamin Suratt, Sanofi, NJ, USA TrialPhase 1 ConferenceATS 2023 12 June, 2023 16:00
Success for fluticasone furoate plus vilanterol in uncontrolled asthma Presented ByDr Philippe Bareille, GSK, UK ConferenceATS 2023 12 June, 2023 00:00
Practice-changing results for ensifentrine in COPD Presented ByProf. Antonio Anzueto, University of Texas Health San Antonio, TX, USA TrialPhase 3, ENHANCE-1, ENHANCE-2 ConferenceATS 2023 12 June, 2023 16:10
Alvelestat for AATD meets primary endpoints in phase 2 trial Presented ByProf. Robert Stockley, University Hospital Birmingham, UK TrialPhase 2, ASTRAEUS ConferenceATS 2023 12 June, 2023 16:08
Fewer exacerbations with dupilumab in COPD with type 2 inflammation Presented ByProf. Klaus Rabe, LungenClinic Grosshansdorf GmbH, Germany TrialPhase 3, BOREAS ConferenceATS 2023 12 June, 2023 16:05
New AATD therapy may alleviate treatment burden for patients Presented ByDr Brooks Kuhn, UC Davis School of Medicine, CA, USA TrialPhase 1 ConferenceATS 2023 12 June, 2023 16:02
Efficient detection of AECOPD with at-home vital signs monitoring Presented ByMr Yann Le Guillou, Biosency, France ConferenceATS 2023 12 June, 2023 15:55
COVA trial: success for the investigational agent sarconeos in hospitalised COVID-19 Presented ByDr Girish Balachandran Nair, Beaumont Hospital, MI, USA TrialPhase 3, COVA ConferenceATS 2023 12 June, 2023 15:57
Mitochondrial DNA levels predict COVID-19 severity Presented ByDr Marlene Cano, Washington University in Saint Louis, MO, USA ConferenceATS 2023 12 June, 2023 15:47
Excellent results for C21 in idiopathic pulmonary fibrosis Presented ByProf. Toby Maher , Keck School of Medicine of USC, USA TrialPhase 2, AIR ConferenceATS 2023 12 June, 2023 16:24
Can camlipixant improve quality of life of patients with refractory chronic cough? Presented ByDr Lorcan McGarvey, Queen’s University Belfast, UK TrialPhase 2, SOOTHE ConferenceATS 2023 12 June, 2023 16:22
TORREY trial: seralutinib associated with reduced pulmonary vascular resistance in PAH Presented ByProf. Robert Frantz, Mayo Clinic, MN, USA TrialPhase 2, TORREY ConferenceATS 2023 12 June, 2023 16:16
Improving quality care in sepsis through machine learning models Presented ByDr Elizabeth Munroe, University of Michigan, MI, USA ConferenceATS 2023 12 June, 2023 15:49
Can information technology improve guideline adherence in sepsis care? Presented ByDr Daniel Leisman, Massachusetts General Hospital, MA, USA ConferenceATS 2023 12 June, 2023 15:45
